SlideShare a Scribd company logo
1 of 30
BY
LAYATMIKA NAYAK
MPHARM
ROLL NO-MPC1837
DEPT OF PHARMACEUTICAL CHEMISTRY
COLLEGE OF PHARMACEUTICAL SCIENCES ,BERHAMPUR.
 IT MAY INCREASE OR DECREASE THE
POTENCY OF THE DRUG.
 IT MAY GIVE UNTOWARD SIDE EFFECTS
 EVEN RIGIDITY OR FLEXIBILITY OF THE
STRUCTURE COUNTS A LOT DURING
DRUG RECEPTOR INTERACTIONS.
oNONSUPERIMPOSABLE ORIENTATIONS OF
MOLECULES DUE TO FREE ROTATIONS
AROUND THE SINGLE BONDS.
oBASIC STRUCTURE,BOND LENGTH AND
BOND ANGLE REMAINS SAME.
 IT SHOULD POSSESS A SINGLE BOND and
shouldnot be present in the ring system.
 Neither of the atoms which are joined by this
single bond can contain three identical
substituents (e.g., three hydrogen atoms, three
methyl groups, etc.) or else rotation about the
bond will be irrevelant.
 Bound to a nonterminal heavy atom Excluded
from the count are amide C–N bonds because
of their high rotational energy barrier .
some conformational isomers for their free rotation around single bonds
RBN = 2
TAKING SIMPLEST
EXAMPLES
•IN ETHANE
STAGGERED IS THE
MOST STABLE
CONFORMER OR
ROTAMER WITH
LEAST POTENTIAL
ENERGY
•IN BUTANE ANTI IS
THE MOST STABLE
CONFORMER.
IMAGINE A DRUG
MOLECULE LIKE
ACETYLCHOLINE
HERE THE
ROTATIONS IS
POSSIBLE BETWEEN 4
AND 5.
TRANS CONFORMER
IS THE MOST STABLE
CONFORMER .
 KNOW THE DIFFERENCE BETWEEN A
PREFERRED CONFORMATIONS AND
ACTIVE CONFORMATIONS
 ADVANTAGES AND DISADVANTAGES OF
CONFORMATIONAL RESTRICTIONS.
•THOUGH INFINITE CONFORMERS ARE
POSSIBLE DUE TO FREE ROTATION AROUND
A SINGLE BOND.
•ALL CONFORMERS ARE NOT OF EQUAL
IMPORTANCE.
•IN 1936,KEMP AND PITZER DETERMINED
THAT
• ROTATIONS OF THE CONFORMER ARE DUE
TO SOME ENERGY BARRIER
•STERIC REPULSION
•ELECTRONIC INTERACTIONS AMONG THE GROUPS.
Conformations which minimize any repulsive
interactions and maximize all attractive interactions
are more energetically favorable than other conformations
and are said to be PREFERRED CONFORMATIONS.
Hence for acyclic compounds conformations where the
larger groups are staggered and separated by greater
distance are more energetically favorable than skew
conformer.
IF FORCE OF ATTRACTION COMPENSATE STERIC
REPULSION FOR EXAMPLE
Gauche Conformer is the most stable one due to
intramolecular hydrogen bonding.
LOOKING INTO THE STERIC CONCEPT IT CAN BE THE STAGGERED
ONE BUT BY SPECTROGRAPHIC ANALYSIS IT IS THE GAUCHE FORM
WHICH IS PREFERRED.
•DUE TO INTRAMOLECULAR ATTRACTION BETWEEN
QUATERNARY NITROGEN AND ESTER CARBONYL
OVERCOMES THE STERIC BARRIER AND STABILIZES IT.
CONSIDERATIONS OF BOTH STERIC AND
ELECTRONIC FACTORS IS REQUIRED.
 DRUG MOLECULE CONFORMER THAT
BINDS TO A RECEPTOR OR AN ENZYME.
 IT CONTAINS THE CORRECT SPATIAL
ARRANGEMENTS OF ALL ESSENTIAL
GROUPS REQUIRED FOR
PHARMACOLOGICAL EFFECT
 IT MAY NOT BE THE PREFERRED ONE.
•IN ACETYLCHOLINE GAUCHE MAY BE THE PREFERRED ONE BUT
TRANS CONFORMER IS USED FOR BINDING WITH MUSCARINIC
RECEPTOR .
•IN TACROLIMUS IT MUST UNDERGO CIS-TRANS ISOMERIZATION OF
THE AMIDE BOND TO BIND TO THE RECEPTOR.
•CYCLOSPORINE IS TURNED INSIDE OUT TO GET ACTIVE BOUND
CONFORMATION LIKE ITS PEPTIDE BOND ISOMERIZES FROM CIS TO
TRANS.
ABOVE EXAMPLES SHOWS
THAT DRUGS SHOULD BE
FLEXIBLE FOR BINDING TO
DRUG RECEPTORS .
 ACTIVE CONFORMATIONS BINDS TO THE
RECEPTORS WITH IDEAS LIKE
 INDUCED FIT THEORY OR ZIPPER
MECHANISM OF BINDING DRUGS.
 IN INDUCED FIT THEORY BY KOSHLAND
STATES THAT THERE IS A CHANGE IN THE
CONFORMATIONS OF THE RECEPTORS
FOR EFFECTIVE BINDING AND TO
PRODUCE A BIOLOGICAL RESPONSE.
 IT IS A DYNAMIC PROCESS WITH MUTUAL
MOLDING OF BOTH RECEPTOR AND
MOLECULE.
CONFORMATIONAL
RESTRICTION
LOCK A MOLECULE IN
DESIRED
CONFORMATIONS.
FOR AN EXAMPLE IF X
AND Y ARE TWO
GROUPS REQUIRED FOR
THERAPEUTIC
PURPOSE AND B AND C
ARE ACTIVE
CONFORMER THEN
RESTRICTION OF A
PARTICULAR
CONFORMATION IS
REQUIRED.
USED AS SPECIFIC AGONIST/ANATAGONIST FOR
RECEPTORS
IT CAN REDUCE UNECESSARY SIDE EFFECTS OF
THE DRUGS.
SINGLE DRUG MOLECULE CAN PROVIDE
DIFFERENT EFFECTS IN THEIR DISTINCT
CONFORMERS.
INCREASED DURATION OF ACTION
THEREFORE A CONFORMATIONALLY ACTIVE
MOLECULE WITH ALL REQUIRED GROUPS IN
PROPER ORIENTATION HAVE HIGH AFFINITY FOR
THE RECEPTORS.
INTRODUCTION OF A DOUBLE BOND
E.g chlorpromazine produces antipsychotic
affects by blocking dopamine receptors.
THE ACTIVE CONFORMER IS THAT IN
WHICH THE NITROGEN IS LOCATED IN THE
CHLORINE CONTAINING AROMATIC RING.
SIDECHAIN IS FLEXIBLE AND NO OF
CONFORMERS ARE POSSIBLE,
INTRODUCTION OF
A DOUBLE BOND
GIVES RISE TO
THIOXANTHENE
(chlorprothixene)CLASS
OF DERIVATIVES
WITH E AND Z
ISOMERS.
FURTHER THE
REQUIRED
BIOACTIVE
CONFORMER IS THE
Z ISOMER THAN E.
 PROVIDES MORE RESTRICTION
 RING CLOSURE MECHANISM TO CHANGE
ACTIVITY OF A PROFILE.
 E.g AMPHETAMINE IS A POTENT CNS
STIMULANT.
TRANYLCYPROMINE IS A POTENT MAO
INHIBITOR
AFTER RING CLOSURE TRANYLCYPROMINE
IS 5000 TIMES MORE POTENT MAO
INHIBITOR THEN AMPHETAMINE.
Phenmetrazine is a cyclic analog of ephedrine. While
Ephedrine a conformationaly flexible molecule, is an
indirect acting adrenergic agonist with CNS stimulating
activity,phenmetrazine a conformationaly restricted
molecule, retains the activity of ephedrine without
pronounced CNS stimulation.
 THE DIRECTION IN WHICH THE RING IS
CLOSED MAY GIVE RISE TO CIS –TRANS
ISOMER
 THE EXTENT OF RESTRICTION IMPOSED
BY THE CLOSURE
CONFORMATIONAL ANALYSIS IS A
REQUIRED PARAMETER TO DETERMINE
THE ACTIVITY OF DRUG MOLECULES. A
BRIEF IDEA ABOUT THESE IS REQUIRED
DURING CHEMICAL DESIGN OF NEW
COMPOUNDS.
 American Journal of Pharmaceutical
Education Vol. 60, Summer 1996
 J. Pharm. Pharmac., 1967, 19, 561-589
 FOYE PRINCIPLES OF MEDICINAL
CHEMISTRY
 Images derived from google search engine.
 Conformations Topic in wikkipedia
isomers

More Related Content

What's hot

1. theories of d r intersctn presentn
1. theories of d r intersctn presentn1. theories of d r intersctn presentn
1. theories of d r intersctn presentn
suniu
 
Drug receptor interactions
Drug receptor interactionsDrug receptor interactions
Drug receptor interactions
raj kumar
 
PCL471Laboratory Slides
PCL471Laboratory SlidesPCL471Laboratory Slides
PCL471Laboratory Slides
Maurice Shen
 

What's hot (20)

Drug receptor-interactions
Drug receptor-interactionsDrug receptor-interactions
Drug receptor-interactions
 
Theories of drug receptor interaction
Theories of drug receptor interactionTheories of drug receptor interaction
Theories of drug receptor interaction
 
Acetamide
AcetamideAcetamide
Acetamide
 
1. theories of d r intersctn presentn
1. theories of d r intersctn presentn1. theories of d r intersctn presentn
1. theories of d r intersctn presentn
 
Lecture 7
Lecture 7Lecture 7
Lecture 7
 
agonist, antagonist and types of antagonism
 agonist, antagonist and types of antagonism agonist, antagonist and types of antagonism
agonist, antagonist and types of antagonism
 
Drug Receptor Binding Forces
Drug Receptor Binding ForcesDrug Receptor Binding Forces
Drug Receptor Binding Forces
 
Drug receptor interactions
Drug receptor interactionsDrug receptor interactions
Drug receptor interactions
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
 
Electronic Parameters used for quantifying Drug - Introduction
Electronic  Parameters used for quantifying Drug - IntroductionElectronic  Parameters used for quantifying Drug - Introduction
Electronic Parameters used for quantifying Drug - Introduction
 
Recent Structure Activity Relationship Studies of 1,4-Benzodiazepines
Recent Structure Activity Relationship Studies of 1,4-BenzodiazepinesRecent Structure Activity Relationship Studies of 1,4-Benzodiazepines
Recent Structure Activity Relationship Studies of 1,4-Benzodiazepines
 
Drug receptor intraction
Drug receptor intractionDrug receptor intraction
Drug receptor intraction
 
Hill equation and plot
Hill equation and plotHill equation and plot
Hill equation and plot
 
PCL471Laboratory Slides
PCL471Laboratory SlidesPCL471Laboratory Slides
PCL471Laboratory Slides
 
Protein ligand interaction.
Protein ligand interaction.Protein ligand interaction.
Protein ligand interaction.
 
Enzyme unit 4 5
Enzyme unit 4  5Enzyme unit 4  5
Enzyme unit 4 5
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptor
 
PROTIEN LIGAND INTERACTIONS
PROTIEN LIGAND INTERACTIONSPROTIEN LIGAND INTERACTIONS
PROTIEN LIGAND INTERACTIONS
 
9.protein ligand interactions2
9.protein ligand interactions29.protein ligand interactions2
9.protein ligand interactions2
 
Ligand interaction by kk sahu
Ligand interaction by kk sahuLigand interaction by kk sahu
Ligand interaction by kk sahu
 

Similar to isomers

Intermolecular interactions
Intermolecular interactionsIntermolecular interactions
Intermolecular interactions
shishirkawde
 

Similar to isomers (20)

SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..
 
opti.pptx
opti.pptxopti.pptx
opti.pptx
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
Pharmacophore Modeling and Docking Techniques.ppt
Pharmacophore Modeling and Docking Techniques.pptPharmacophore Modeling and Docking Techniques.ppt
Pharmacophore Modeling and Docking Techniques.ppt
 
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsClinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Chapter 5 allosteric drug effects
Chapter 5  allosteric drug effectsChapter 5  allosteric drug effects
Chapter 5 allosteric drug effects
 
RATIONAL DRUG DESIGN.pptx
RATIONAL DRUG DESIGN.pptxRATIONAL DRUG DESIGN.pptx
RATIONAL DRUG DESIGN.pptx
 
Molecular orbital theory
Molecular orbital theoryMolecular orbital theory
Molecular orbital theory
 
Advanced Medicinal Chemistry of GPCR Receptor
Advanced Medicinal Chemistry of GPCR ReceptorAdvanced Medicinal Chemistry of GPCR Receptor
Advanced Medicinal Chemistry of GPCR Receptor
 
(Strategies in drug design for optimization of pharmacodynamics).pptx
(Strategies in drug design for optimization of pharmacodynamics).pptx(Strategies in drug design for optimization of pharmacodynamics).pptx
(Strategies in drug design for optimization of pharmacodynamics).pptx
 
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal ChemistryFUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
 
steric effect.pptx
steric effect.pptxsteric effect.pptx
steric effect.pptx
 
Panushka UROP (1)
Panushka UROP (1)Panushka UROP (1)
Panushka UROP (1)
 
motiei2016
motiei2016motiei2016
motiei2016
 
5 mechanisms of drug action
5 mechanisms of drug action5 mechanisms of drug action
5 mechanisms of drug action
 
Intermolecular interactions
Intermolecular interactionsIntermolecular interactions
Intermolecular interactions
 
POLYMERS IN SOLID STATE, PHARMACEUTICAL APPLICATIONS OF POLYMERS AND RECENT A...
POLYMERS IN SOLID STATE, PHARMACEUTICAL APPLICATIONS OF POLYMERS AND RECENT A...POLYMERS IN SOLID STATE, PHARMACEUTICAL APPLICATIONS OF POLYMERS AND RECENT A...
POLYMERS IN SOLID STATE, PHARMACEUTICAL APPLICATIONS OF POLYMERS AND RECENT A...
 
Allosteric enzymes regulation
Allosteric enzymes  regulationAllosteric enzymes  regulation
Allosteric enzymes regulation
 
Stereochemistry
StereochemistryStereochemistry
Stereochemistry
 

Recently uploaded

LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
Cherry
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
seri bangash
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
Scintica Instrumentation
 

Recently uploaded (20)

Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspects
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
 
GBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) MetabolismGBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) Metabolism
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolation
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
 
Cot curve, melting temperature, unique and repetitive DNA
Cot curve, melting temperature, unique and repetitive DNACot curve, melting temperature, unique and repetitive DNA
Cot curve, melting temperature, unique and repetitive DNA
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Site specific recombination and transposition.........pdf
Site specific recombination and transposition.........pdfSite specific recombination and transposition.........pdf
Site specific recombination and transposition.........pdf
 
X-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center ChimneyX-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
 
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate ProfessorThyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdf
 
Understanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution MethodsUnderstanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution Methods
 
Plasmid: types, structure and functions.
Plasmid: types, structure and functions.Plasmid: types, structure and functions.
Plasmid: types, structure and functions.
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
 

isomers

  • 1. BY LAYATMIKA NAYAK MPHARM ROLL NO-MPC1837 DEPT OF PHARMACEUTICAL CHEMISTRY COLLEGE OF PHARMACEUTICAL SCIENCES ,BERHAMPUR.
  • 2.  IT MAY INCREASE OR DECREASE THE POTENCY OF THE DRUG.  IT MAY GIVE UNTOWARD SIDE EFFECTS  EVEN RIGIDITY OR FLEXIBILITY OF THE STRUCTURE COUNTS A LOT DURING DRUG RECEPTOR INTERACTIONS.
  • 3. oNONSUPERIMPOSABLE ORIENTATIONS OF MOLECULES DUE TO FREE ROTATIONS AROUND THE SINGLE BONDS. oBASIC STRUCTURE,BOND LENGTH AND BOND ANGLE REMAINS SAME.
  • 4.  IT SHOULD POSSESS A SINGLE BOND and shouldnot be present in the ring system.  Neither of the atoms which are joined by this single bond can contain three identical substituents (e.g., three hydrogen atoms, three methyl groups, etc.) or else rotation about the bond will be irrevelant.  Bound to a nonterminal heavy atom Excluded from the count are amide C–N bonds because of their high rotational energy barrier .
  • 5. some conformational isomers for their free rotation around single bonds RBN = 2
  • 6. TAKING SIMPLEST EXAMPLES •IN ETHANE STAGGERED IS THE MOST STABLE CONFORMER OR ROTAMER WITH LEAST POTENTIAL ENERGY •IN BUTANE ANTI IS THE MOST STABLE CONFORMER.
  • 7.
  • 8. IMAGINE A DRUG MOLECULE LIKE ACETYLCHOLINE HERE THE ROTATIONS IS POSSIBLE BETWEEN 4 AND 5. TRANS CONFORMER IS THE MOST STABLE CONFORMER .
  • 9.  KNOW THE DIFFERENCE BETWEEN A PREFERRED CONFORMATIONS AND ACTIVE CONFORMATIONS  ADVANTAGES AND DISADVANTAGES OF CONFORMATIONAL RESTRICTIONS.
  • 10. •THOUGH INFINITE CONFORMERS ARE POSSIBLE DUE TO FREE ROTATION AROUND A SINGLE BOND. •ALL CONFORMERS ARE NOT OF EQUAL IMPORTANCE. •IN 1936,KEMP AND PITZER DETERMINED THAT • ROTATIONS OF THE CONFORMER ARE DUE TO SOME ENERGY BARRIER
  • 11. •STERIC REPULSION •ELECTRONIC INTERACTIONS AMONG THE GROUPS. Conformations which minimize any repulsive interactions and maximize all attractive interactions are more energetically favorable than other conformations and are said to be PREFERRED CONFORMATIONS.
  • 12. Hence for acyclic compounds conformations where the larger groups are staggered and separated by greater distance are more energetically favorable than skew conformer.
  • 13. IF FORCE OF ATTRACTION COMPENSATE STERIC REPULSION FOR EXAMPLE Gauche Conformer is the most stable one due to intramolecular hydrogen bonding.
  • 14. LOOKING INTO THE STERIC CONCEPT IT CAN BE THE STAGGERED ONE BUT BY SPECTROGRAPHIC ANALYSIS IT IS THE GAUCHE FORM WHICH IS PREFERRED. •DUE TO INTRAMOLECULAR ATTRACTION BETWEEN QUATERNARY NITROGEN AND ESTER CARBONYL OVERCOMES THE STERIC BARRIER AND STABILIZES IT.
  • 15. CONSIDERATIONS OF BOTH STERIC AND ELECTRONIC FACTORS IS REQUIRED.
  • 16.  DRUG MOLECULE CONFORMER THAT BINDS TO A RECEPTOR OR AN ENZYME.  IT CONTAINS THE CORRECT SPATIAL ARRANGEMENTS OF ALL ESSENTIAL GROUPS REQUIRED FOR PHARMACOLOGICAL EFFECT  IT MAY NOT BE THE PREFERRED ONE.
  • 17. •IN ACETYLCHOLINE GAUCHE MAY BE THE PREFERRED ONE BUT TRANS CONFORMER IS USED FOR BINDING WITH MUSCARINIC RECEPTOR . •IN TACROLIMUS IT MUST UNDERGO CIS-TRANS ISOMERIZATION OF THE AMIDE BOND TO BIND TO THE RECEPTOR. •CYCLOSPORINE IS TURNED INSIDE OUT TO GET ACTIVE BOUND CONFORMATION LIKE ITS PEPTIDE BOND ISOMERIZES FROM CIS TO TRANS. ABOVE EXAMPLES SHOWS THAT DRUGS SHOULD BE FLEXIBLE FOR BINDING TO DRUG RECEPTORS .
  • 18.  ACTIVE CONFORMATIONS BINDS TO THE RECEPTORS WITH IDEAS LIKE  INDUCED FIT THEORY OR ZIPPER MECHANISM OF BINDING DRUGS.  IN INDUCED FIT THEORY BY KOSHLAND STATES THAT THERE IS A CHANGE IN THE CONFORMATIONS OF THE RECEPTORS FOR EFFECTIVE BINDING AND TO PRODUCE A BIOLOGICAL RESPONSE.  IT IS A DYNAMIC PROCESS WITH MUTUAL MOLDING OF BOTH RECEPTOR AND MOLECULE.
  • 19.
  • 20. CONFORMATIONAL RESTRICTION LOCK A MOLECULE IN DESIRED CONFORMATIONS. FOR AN EXAMPLE IF X AND Y ARE TWO GROUPS REQUIRED FOR THERAPEUTIC PURPOSE AND B AND C ARE ACTIVE CONFORMER THEN RESTRICTION OF A PARTICULAR CONFORMATION IS REQUIRED.
  • 21. USED AS SPECIFIC AGONIST/ANATAGONIST FOR RECEPTORS IT CAN REDUCE UNECESSARY SIDE EFFECTS OF THE DRUGS. SINGLE DRUG MOLECULE CAN PROVIDE DIFFERENT EFFECTS IN THEIR DISTINCT CONFORMERS. INCREASED DURATION OF ACTION
  • 22. THEREFORE A CONFORMATIONALLY ACTIVE MOLECULE WITH ALL REQUIRED GROUPS IN PROPER ORIENTATION HAVE HIGH AFFINITY FOR THE RECEPTORS.
  • 23. INTRODUCTION OF A DOUBLE BOND E.g chlorpromazine produces antipsychotic affects by blocking dopamine receptors. THE ACTIVE CONFORMER IS THAT IN WHICH THE NITROGEN IS LOCATED IN THE CHLORINE CONTAINING AROMATIC RING. SIDECHAIN IS FLEXIBLE AND NO OF CONFORMERS ARE POSSIBLE,
  • 24. INTRODUCTION OF A DOUBLE BOND GIVES RISE TO THIOXANTHENE (chlorprothixene)CLASS OF DERIVATIVES WITH E AND Z ISOMERS. FURTHER THE REQUIRED BIOACTIVE CONFORMER IS THE Z ISOMER THAN E.
  • 25.  PROVIDES MORE RESTRICTION  RING CLOSURE MECHANISM TO CHANGE ACTIVITY OF A PROFILE.  E.g AMPHETAMINE IS A POTENT CNS STIMULANT. TRANYLCYPROMINE IS A POTENT MAO INHIBITOR AFTER RING CLOSURE TRANYLCYPROMINE IS 5000 TIMES MORE POTENT MAO INHIBITOR THEN AMPHETAMINE.
  • 26. Phenmetrazine is a cyclic analog of ephedrine. While Ephedrine a conformationaly flexible molecule, is an indirect acting adrenergic agonist with CNS stimulating activity,phenmetrazine a conformationaly restricted molecule, retains the activity of ephedrine without pronounced CNS stimulation.
  • 27.  THE DIRECTION IN WHICH THE RING IS CLOSED MAY GIVE RISE TO CIS –TRANS ISOMER  THE EXTENT OF RESTRICTION IMPOSED BY THE CLOSURE
  • 28. CONFORMATIONAL ANALYSIS IS A REQUIRED PARAMETER TO DETERMINE THE ACTIVITY OF DRUG MOLECULES. A BRIEF IDEA ABOUT THESE IS REQUIRED DURING CHEMICAL DESIGN OF NEW COMPOUNDS.
  • 29.  American Journal of Pharmaceutical Education Vol. 60, Summer 1996  J. Pharm. Pharmac., 1967, 19, 561-589  FOYE PRINCIPLES OF MEDICINAL CHEMISTRY  Images derived from google search engine.  Conformations Topic in wikkipedia